Literature DB >> 11031798

Diagnosis and treatment of HIV-associated neurocognitive disorders.

S J Ferrando1.   

Abstract

Although significant strides have been made in recent years in treating HIV disease with new antiretroviral medications, the management of neurocognitive disorders continues to remain a challenge. This chapter provides an overview of the current epidemiology, neuropathogenesis, clinical features, diagnosis, and treatment of the central nervous system complications of HIV infection.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11031798     DOI： 10.1002/yd.23320008705

Source DB:  PubMed          Journal:  New Dir Ment Health Serv        ISSN： 0193-9416


  6 in total

1.  Effect of progression of disease on cognitive performance in HIV/AIDS.

Authors:  Francis Odiase; Olubunmi Ogunrin; Adesola Ogunniyi
Journal:  J Natl Med Assoc       Date:  2006-08       Impact factor: 1.798

2.  Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD).

Authors:  Jon Salemi; Demian F Obregon; Anthony Cobb; Spenser Reed; Edin Sadic; Jingji Jin; Francisco Fernandez; Jun Tan; Brian Giunta
Journal:  Mol Neurodegener       Date:  2011-01-11       Impact factor: 14.195

3.  Cognitive functions in newly diagnosed patients with HIV infection in a tertiary health facility: Assessment using community screening interview for dementia.

Authors:  T A Sumonu; F Imarhiagbe; L F Owolabi; O A Ogunrin; M A Komolafe; O S Ilesanmi
Journal:  eNeurologicalSci       Date:  2017-10-24

4.  Cognitive function in patients with newly diagnosed HIV infection in a tertiary health facility in south - west Nigeria: Assessment using computer-assisted neuropsychological test battery.

Authors:  Taofiki A Sunmonu; Olubunmi A Ogunrin; Frank A Imarhiagbe; Lukman F Owolabi; Morenikeji A Komolafe; Olayinka S Llesanmi
Journal:  eNeurologicalSci       Date:  2016-02-24

5.  Neuropsychological, Medical, and Psychiatric Findings After Recovery From Acute COVID-19: A Cross-sectional Study.

Authors:  Stephen J Ferrando; Rhea Dornbush; Sean Lynch; Sivan Shahar; Lidia Klepacz; Carol L Karmen; Donald Chen; Stephen A Lobo; Dania Lerman
Journal:  J Acad Consult Liaison Psychiatry       Date:  2022-01-25

6.  STAT1 regulates human glutaminase 1 promoter activity through multiple binding sites in HIV-1 infected macrophages.

Authors:  Lixia Zhao; Yunlong Huang; Jialin Zheng
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.